Elicera Therapeutics AB (OSTO:ELIC) FCF Yield % : -44.49 (As of May. 23, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Elicera Therapeutics AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Elicera Therapeutics AB's Trailing 12-Month Free Cash Flow is kr-14.92 Mil, and Market Cap is kr33.55 Mil. Therefore, Elicera Therapeutics AB's FCF Yield % for today is -44.49%.

The historical rank and industry rank for Elicera Therapeutics AB's FCF Yield % or its related term are showing as below:

OSTO:ELIC' s FCF Yield % Range Over the Past 10 Years
Min: -49.92 Med: 0 Max: 0
Current: -44.49

OSTO:ELIC's FCF Yield % is ranked worse than
73.68% of 1554 companies
in the Biotechnology industry
Industry Median: -14.335 vs OSTO:ELIC: -44.49

Elicera Therapeutics AB's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Elicera Therapeutics AB FCF Yield % Historical Data

The historical data trend for Elicera Therapeutics AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elicera Therapeutics AB FCF Yield % Chart

Elicera Therapeutics AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-14.39

-12.33

-16.54

Elicera Therapeutics AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial												31.73	-11.34	-15.23	-99.66	15.53

Competitive Comparison of Elicera Therapeutics AB's FCF Yield %

For the Biotechnology subindustry, Elicera Therapeutics AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elicera Therapeutics AB's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Elicera Therapeutics AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Elicera Therapeutics AB's FCF Yield % falls into.

Elicera Therapeutics AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Elicera Therapeutics AB's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-14.924	/	90.20592
	=	-16.54%

Elicera Therapeutics AB's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	3.503	*	4	/	90.20592
	=	15.53%

Elicera Therapeutics AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Elicera Therapeutics AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of Elicera Therapeutics AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Elicera Therapeutics AB (OSTO:ELIC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Elicera Therapeutics AB (OSTO:ELIC) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

8E8:Germany

Address

Massans gata 10, World Trade Center Goteborg, 7th Floor, Goteborg, SWE, SE-412 51

Website

https://www.elicera.com

Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments. The company's product portfolio consists of four drug candidates, two in the field of oncolytic viruses (ELC-100 and ELC-201) and two in the field of CAR T-cell treatments (ELC-301 and ELC-401), in addition to a universal CAR T-cell technology platform, iTANK (ELC-001), compatible with any CAR T-cell therapy for a multi-targeted attack on solid tumors.

Elicera Therapeutics AB (OSTO:ELIC) Headlines

No Headlines